# 2026-04532: NIH Drops Super-Vaccines: 100% Mouse Protection Against Malaria!

2026-04532, Government-Owned Inventions; Availability for Licensing, is a Federal Register notice from Health and Human Services Department, National Institutes of Health published 2026-03-09, effective 2026-03-09; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-04532
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-04532
- Title: Government-Owned Inventions; Availability for Licensing
- Type: Notice
- Agencies: Health and Human Services Department; National Institutes of Health
- Citation: 91 FR 11329
- Published: 2026-03-09
- Effective: 2026-03-09
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

NIH Drops Super-Vaccines: 100% Mouse Protection Against Malaria!

## Summary

The National Institutes of Health is offering new malaria vaccine inventions for companies to license and develop. These cool nanoparticle platforms show promise in making vaccines super effective, with early tests in mice showing 100% protection. If you’re a business or researcher ready to jump in, now’s the time to connect and start working with these government-owned inventions!

## Abstract

The National Institute of Allergy and Infectious Diseases (NIAID), an institute of the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is giving notice of the invention listed below, which is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.

## Effects PRIA read

- NIH Offers Malaria Vaccine Tech For Licensing: benefit, medium. The National Institute of Allergy and Infectious Diseases (NIAID/NIH) is offering three engineered nanoparticle vaccine platforms for licensing and commercial development under 35 U.S.C. 209 and 37 CFR part 404. The platforms include a PLP synthase nanoparticle displaying 48 copies of up to 4 prote…
- Patent Filings Cover Technology: benefit, medium. The technology is covered by patent filings: U.S. Provisional Patent Application No. 63/695,288 filed on September 16, 2024, and PCT Patent Application No. PCT/US2025/046419 filed on September 15, 2025. The notice says foreign patent applications have been filed on selected inventions to extend mar…
- Opportunity For Collaborative Research: benefit, low. NIAID is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize these malaria vaccine nanoparticle technologies. Interested parties should contact Chris Kornak at 240-565-2632 or [email protected] to express inte…
- Pre-Clinical Data Shows 100% Protection In Mice: benefit, medium. Pre-clinical data reported in the notice show that nanoparticles displaying the malaria circumsporozoite protein (CSP) conferred 100% sterilizing immunity in mice, and the work is described as being at the pre-clinical developmental stage. The publication cited is: Shi D, et al., Nat Microbiol. 202…

## Related documents

- [2026-22871](https://policyrisk.com/federal-register/2026-22871): Center for Scientific Review; Notice of Closed Meetings, 2026-11-10
- [2026-22550](https://policyrisk.com/federal-register/2026-22550): Center for Scientific Review; Notice of Closed Meetings, 2026-11-05
- [2026-22558](https://policyrisk.com/federal-register/2026-22558): Center for Scientific Review; Notice of Closed Meetings, 2026-11-05
- [2026-22339](https://policyrisk.com/federal-register/2026-22339): Prospective Grant of Exclusive Patent License: Catheter-Based Intramyocardial Ablation for Treating Ventricular Arrhythmia in a Human, 2026-11-02
- [2026-22196](https://policyrisk.com/federal-register/2026-22196): National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting, 2026-10-30
- [2026-22111](https://policyrisk.com/federal-register/2026-22111): Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting, 2026-10-29

## Sources
- [2026-04532 on federalregister.gov](https://www.federalregister.gov/documents/2026/03/09/2026-04532/government-owned-inventions-availability-for-licensing)
- [2026-04532 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-03-09/pdf/2026-04532.pdf)

## Related
- [Previous: 2026-04530, Agency Information Collection Activities; Submission to the Office of Managemen…](https://policyrisk.com/federal-register/2026-04530)
- [Next: 2026-04535, Agency Information Collection Activities: Submission to OMB for Review and Appr…](https://policyrisk.com/federal-register/2026-04535)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-04532 (as of 2026-06-08).
